Exclusive

Publication

Byline

Location

Clinical Trial: Comparison of Two Autogenous Bone and Xenograft Ratios for Horizontal Ridge Augmentation

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07865624) titled 'Comparison of Two Autogenous Bone and Xenograft Ratios for Horizontal Ridge Augmentation' on... Read More


Singapore Clinical Trial: A Phase 1, Open-Label, Pharmacokinetic Study of Lepodisiran Administered as a Single Subcutaneous Dose in the Abdomen, Thigh, or Upper Arm in Healthy Participants with High Lipoprotein(a)

Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open-Label, Pharmacokinetic Study of Lepodisiran Administered as a Single Subcutaneous D... Read More


Clinical Trial: Vitamin D Status and Its Influencing Factors in Zhejiang Province: A Multicenter Cross-Sectional Study

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07866391) titled 'Vitamin D Status and Its Influencing Factors in Zhejiang Province: A Multicenter Cross-Secti... Read More


Singapore Clinical Trial: A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Severe... Read More


Singapore Clinical Trial: Evaluating the Year-Round Immunogenicity of Standard-Dose Versus High-Dose Seasonal Influenza Vaccines in Adults Aged 60 Years or Older in Singapore (SingVax-01)

Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'Evaluating the Year-Round Immunogenicity of Standard-Dose Versus High-Dose Seasonal Influenza Vacci... Read More


Singapore Clinical Trial: Beamion LUNG-1: An open label, Phase I dose escalation trial, with dose confirmation and expansion, of zongertinib (BI 1810631) as monotherapy in patients with advanced or metastatic solid tumors with HER2 aberrations

Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-1: An open label, Phase I dose escalation trial, with dose confirmation and expansion,... Read More


Clinical Trial: Evaluation of Dapagliflozin and Empagliflozin as Adjunctive Therapy to Methotrexate in Patients With Rheumatoid Arthritis

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07864688) titled 'Evaluation of Dapagliflozin and Empagliflozin as Adjunctive Therapy to Methotrexate in Patie... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamide Compared with ARPI or Docetaxel in Patients with Metastatic Castration Resistant Prostate Cancer Previously Treated with Abiraterone Acetate (Himalayas-1)

Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamid... Read More


Singapore Clinical Trial: Tucatinib continuation protocol: an open label study for participants from tucatinib clinical studies

Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'Tucatinib continuation protocol: an open label study for participants from tucatinib clinical studi... Read More


Clinical Trial: Adapting and Implementing a Chronic Disease Self-Management Program for Primary Care Patients With Opioid Use Disorder and Serious Mental Illness.

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07865078) titled 'Adapting and Implementing a Chronic Disease Self-Management Program for Primary Care Patient... Read More